BioStock Investor Meeting: Interview with OssDsign

In connection with the BioStock Investor Meeting in Stockholm, BioStock’s reporter was visited by Anders Svensson, CFO of OssDsign. Svensson told us more about OssDsign’s products for regenerative implants and patient-specific solutions for the treatment of bone defects. He also answered the question of what distinguishes OssDsign’s products from competitors and elaborated on the company’s road map for growth.

Read the article at biostock.se:

https://www.biostock.se/en/2022/09/biostock-investor-meeting-interview-with-ossdsign/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/